These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 663972
1. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis. Yasuhara M, Kuramoto T, Hoshita T, Itoga E, Kito S. Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972 [Abstract] [Full Text] [Related]
2. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T. J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361 [Abstract] [Full Text] [Related]
3. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis. Kuramoto T, Suemura Y, Kihira K, Hiraoka T, Hoshita T. Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780 [Abstract] [Full Text] [Related]
4. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. Hoshita T, Yasuhara M, Une M, Kibe A, Itoga E, Kito S, Kuramoto T. J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799 [Abstract] [Full Text] [Related]
5. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis. Kihira K, Kubota A, Hoshita T. J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531 [Abstract] [Full Text] [Related]
7. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. Batta AK, Shefer S, Batta M, Salen G. J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647 [Abstract] [Full Text] [Related]
8. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis. Dayal B, Tint GS, Greeley DN, Williams TH, Salen G. Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948 [Abstract] [Full Text] [Related]
9. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis. Dayal B, Tint GS, Toome V, Batta AK, Shefer S, Salen G. J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722 [Abstract] [Full Text] [Related]
10. Bile alcohol glucuronides: regioselective O-glucuronidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol. Dayal B, Salen G, Padia J, Shefer S, Tint GS, Sasso G, Williams TH. Carbohydr Res; 1993 Feb 24; 240():133-42. PubMed ID: 8458007 [Abstract] [Full Text] [Related]
12. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis. Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS. J Clin Invest; 1979 Jan 24; 63(1):38-44. PubMed ID: 762246 [Abstract] [Full Text] [Related]
13. Identification of bile alcohols in human bile. Kuroki S, Shimazu K, Kuwabara M, Une M, Kihira K, Kuramoto T, Hoshita T. J Lipid Res; 1985 Feb 24; 26(2):230-40. PubMed ID: 3989382 [Abstract] [Full Text] [Related]
14. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study. Kuramoto T, Fukuda K, Ohshima A, Kihira K, Hoshita T. J Biochem; 1994 Apr 24; 115(4):655-8. PubMed ID: 8089079 [Abstract] [Full Text] [Related]
15. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. Oftebro H, Björkhem I, Skrede S, Schreiner A, Pederson JI. J Clin Invest; 1980 Jun 24; 65(6):1418-30. PubMed ID: 7410549 [Abstract] [Full Text] [Related]
16. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid. Salen G, Shefer S, Setoguchi T, Mosbach EH. J Clin Invest; 1975 Jul 24; 56(1):226-31. PubMed ID: 1141434 [Abstract] [Full Text] [Related]
17. Radioimmunoassay of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide in serum of patients with cerebrotendinous xanthomatosis. Une M, Kataoka J, Nakata Y, Hoshita T. Steroids; 1992 Jan 24; 57(1):32-6. PubMed ID: 1585391 [Abstract] [Full Text] [Related]
18. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands. Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A. J Inherit Metab Dis; 1988 Jan 24; 11(1):56-75. PubMed ID: 3128689 [Abstract] [Full Text] [Related]
19. Metabolism of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 26-tetrol and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol into cholic acid in normal human subjects. Hanson RF, Staples AB, Williams GC. J Lipid Res; 1979 May 24; 20(4):489-93. PubMed ID: 458268 [Abstract] [Full Text] [Related]
20. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study). Dayal B, Tint GS, Shefer S, Salen G. Steroids; 1979 Mar 24; 33(3):327-38. PubMed ID: 442127 [Abstract] [Full Text] [Related] Page: [Next] [New Search]